EMEAX
Price
$12.37
Change
-$0.23 (-1.83%)
Updated
Jun 13 closing price
Net Assets
179.27M
RNWHX
Price
$84.97
Change
-$1.04 (-1.21%)
Updated
Jun 13 closing price
Net Assets
67.74B
Interact to see
Advertisement

EMEAX vs RNWHX

Header iconEMEAX vs RNWHX Comparison
Open Charts EMEAX vs RNWHXBanner chart's image
Ashmore Emerging Markets Equity A
Price$12.37
Change-$0.23 (-1.83%)
VolumeN/A
Net Assets179.27M
American Funds New World R5E
Price$84.97
Change-$1.04 (-1.21%)
VolumeN/A
Net Assets67.74B
EMEAX vs RNWHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMEAX vs. RNWHX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMEAX is a Buy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 67.7B vs. EMEAX (179M). RNWHX pays higher dividends than EMEAX: RNWHX (1.04) vs EMEAX (0.39). EMEAX was incepted earlier than RNWHX: EMEAX (13 years) vs RNWHX (10 years). EMEAX (1.76) is less costly to investors than RNWHX (0.72). EMEAX is a more actively managed with annual turnover of: 103.00 vs. RNWHX (37.00). RNWHX has a lower initial minimum investment than EMEAX: RNWHX (250) vs EMEAX (1000). RNWHX annual gain was more profitable for investors over the last year : 8.20 vs. EMEAX (7.64). RNWHX return over 5 years is better than : 33.47 vs. EMEAX (16.89).
EMEAXRNWHXEMEAX / RNWHX
Total Expense Ratio1.300.72181%
Annual Report Gross Expense Ratio1.760.72244%
Fund Existence13 years10 years-
Gain YTD11.04111.77394%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets179M67.7B0%
Annual Yield % from dividends0.391.0438%
Returns for 1 year7.648.2093%
Returns for 3 years31.3835.0989%
Returns for 5 years16.8933.4750%
Returns for 10 years58.26N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALNY307.993.32
+1.09%
Alnylam Pharmaceuticals
DNB9.04-0.02
-0.22%
Dun & Bradstreet Holdings
CSWC20.65-0.23
-1.10%
Capital Southwest Corp
SWAG1.43-0.05
-3.38%
Stran & Company
INVZ0.92-0.05
-4.78%
Innoviz Technologies Ltd